Found 44 matching trials
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer PHASE3 RATIONALE: Radioactive iodine uses radiation to kill tumor cells. Giving io...
Show More Location
Sussex Cancer Centre at Royal Sussex County Hospital
Learn More & Join Trial
Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC PHASE2 This research is being done to determine the efficacy of selpercatinib to r...
Show More Location
MedStar Washington Hospital Center
Learn More & Join Trial
Salivary dysfuncTion After Radioiodine Treatment N/A Aim/Introduction:
The treatment of differentiated thyroid cancer includes ...
Show More Location
Pitié-Salpêtrière hospital
Learn More & Join Trial
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer PHASE2 Study rationale
High risk patients with differentiated thyroid cancer (DTC...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer NA The goal of this study is to learn if a decision aid (DA) website helps peo...
Show More Location
Lombardi Comprehensive Cancer Center
Learn More & Join Trial
The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma N/A Clinincal data and pathological specimens from patients who had undergone a...
Show More Status
Active Not Recruiting
Location
Jiangxi Cancer Hospital
Learn More & Join Trial
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery PHASE1 This phase I trial is studying the side effects and best dose of iodine I 1...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation PHASE2 This phase II trial tests how well vemurafenib and cobimetinib work in trea...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer PHASE1 RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to ...
Show More Location
Albert B. Chandler Medical Center, University of Kentucky
Learn More & Join Trial
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59) PHASE1 The purpose of this study is to find out if your adrenal glands are normal ...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial